Monitoring metabolic response using FDG PET-CT during targeted therapy for metastatic colorectal cancer

about

Monitoring metabolic response using FDG PET-CT during targeted therapy for metastatic colorectal cancer

Item

http://www.wikidata.org/entity/Q37143791

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 12 April 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Monitoring metabolic response ...... r metastatic colorectal cancer

@en

Monitoring metabolic response ...... metastatic colorectal cancer.

@nl

type

Item

label

Monitoring metabolic response ...... r metastatic colorectal cancer

@en

Monitoring metabolic response ...... metastatic colorectal cancer.

@nl

prefLabel

Monitoring metabolic response ...... r metastatic colorectal cancer

@en

Monitoring metabolic response ...... metastatic colorectal cancer.

@nl

P1476

Monitoring metabolic response ...... r metastatic colorectal cancer

@en

P2093

Alain Hendlisz

http://www.w3.org/2001/XMLSchema#string

Amelie Deleporte

http://www.w3.org/2001/XMLSchema#string

Camilo Garcia

http://www.w3.org/2001/XMLSchema#string

Gauthier Demolin

http://www.w3.org/2001/XMLSchema#string

Irina Vierasu

http://www.w3.org/2001/XMLSchema#string

Lieveke Ameye

http://www.w3.org/2001/XMLSchema#string

Marc Van den Eynde

http://www.w3.org/2001/XMLSchema#string

Namur Gauthier

http://www.w3.org/2001/XMLSchema#string

Patrick Flamen

http://www.w3.org/2001/XMLSchema#string

Raphaël Maréchal

http://www.w3.org/2001/XMLSchema#string

P2860

Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012

Guidelines for the evaluation of immune therapy activity in solid tumors: immune-related response criteria

Regorafenib assessment in refractory advanced colorectal cancer: RegARd-C study protocol

Toxicity and response criteria of the Eastern Cooperative Oncology Group

Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trial

Accelerated image reconstruction using ordered subsets of projection data.

Measurement of clinical and subclinical tumour response using [18F]-fluorodeoxyglucose and positron emission tomography: review and 1999 EORTC recommendations. European Organization for Research and Treatment of Cancer (EORTC) PET Study Group.

Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification

From RECIST to PERCIST: Evolving Considerations for PET response criteria in solid tumors.

CT versus FDG-PET/CT response evaluation in patients with metastatic colorectal cancer treated with irinotecan and cetuximab.

P2888

s00259-016-3365-x

P304

1792-1801

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00259-016-3365-X

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

E Woff

P577

2016-04-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27072811

http://www.w3.org/2001/XMLSchema#string

P921

colorectal cancer

P932

4969337

http://www.w3.org/2001/XMLSchema#string